Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2011-04-27 07:00:00

Without GI protection, 87 per cent of NSAID users are at increased risk of developing GI complications To view the Social Media Release, click here: http://smr.newswire.ca/en/vimovo/health-canada-approves-vimovo MISSISSAUGA, ON, April 27 /PRNewswire/ - AstraZeneca Canada Inc. announced today that Health Canada has approved VIMOVO(®) modified-release tablets for the treatment of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing...

2011-04-26 23:01:00

BALTIMORE, April 27, 2011 /PRNewswire/ -- The American Pain Foundation (APF) announced today the launch of new information and resources on pain medication safety for acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) as a part of its PainSAFE(TM) educational initiative. The new information will be launched with a national public service announcement (PSA) emphasizing the safe use of pain treatment options, particularly medications containing NSAIDs (aspirin, ibuprofen,...

2011-04-11 05:00:00

DENVER, April 11, 2011 /PRNewswire/ -- Life-saving Colorado start-up UrgentRx today announced the company's new line of fast-acting, powdered medications in convenient credit card-sized packets are available now at Dahl's pharmacies, Hy-Vee grocery stores, and convenience stores throughout Iowa. UrgentRx® first made its powdered medications available across Colorado in February. The company's initial product line consists of UrgentRx Aspirin to Go, UrgentRx Headache...

2011-04-06 16:00:35

Results may lead to safer chemoprevention Numerous studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colon cancer. However, animal studies testing the NSAID naproxen or its derivative, NO-naproxen, have focused primarily on chemically-induced tumor formation. Now, researchers at Fox Chase Cancer Center find that naproxen and NO-naproxen reduce tumor formation in a strain of mutant mice that spontaneously develop colon tumors. The data also suggest that...

2011-04-06 07:48:18

(Ivanhoe Newswire) -- The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to new research. "The results are not meant to suggest everyone should start taking aspirin once monthly to reduce their risk of pancreatic cancer," Xiang-Lin Tan, Ph.D., M.D., a research fellow at Mayo Clinic in Rochester, Minn., was quoted as saying. "Individuals should discuss use of aspirin with their physicians because the drug carries some side...

2011-04-04 13:32:48

The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6. Xiang-Lin Tan, Ph.D., M.D., a research fellow at Mayo Clinic in Rochester, Minn., said the findings from this large collaborative study are preliminary and do not encourage widespread use of aspirin for this purpose. "The results are not meant to suggest everyone...

d65c28e51b9ba364c89e9ecd72dc0d6f
2011-04-02 06:55:00

Conclusions of a new study do not help to ease any confusion over whether use of painkillers reduces the risk of developing the dangerous skin cancer melanoma. Laboratory experiments with animals have suggested that painkillers known as nonsteroidal inflammatory drugs (NSAIDs) may play a role in preventing melanoma, but a 2008 study failed to find evidence supporting the possibility. Now, however, according to results of a new study, researchers say NSAIDs could offer some protection...

2011-03-24 06:30:00

HONG KONG, March 24 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC BB:ALRX.OB) has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment. AlphaRx has developed three formulations using ARX8203, an injectable formulation for post-surgical pain, an oral capsule for chronic pain and an ophthalmic formulation for ocular inflammation. AlphaRx has eight...

2011-03-23 14:36:27

Complete drug statistics from the Norwegian Institute of Public Health After many years of gradual increase followed by a three-year levelling off period, sales of addictive anxiolytic and hypnotic drugs decreased by just under two per cent in 2010. This comes from the new report "Drug Consumption in Norway 2006-2010". The statistics include all sales of prescription and OTC drugs in Norway from wholesalers to pharmacies, hospitals / nursing homes and grocery stores. The report also shows...

2011-03-09 14:18:59

Elevations in novel inflammatory marker predict who may benefit from preventive treatment The reduced risk of colorectal cancer associated with taking aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may be confined to individuals already at risk because of elevations in a particular inflammatory factor in the blood. In a paper in the March issue of Gastroenterology, investigators from Massachusetts General Hospital (MGH) and Dana-Farber Cancer Institute report finding that...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related